3rd Quarter - Report

BOSTON SCIENTIFIC CORPORATION for BOSTON SCIENTIFIC CORPORATION

Firm
Client
Income
—
Expenses
$410,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

United States-Korea Free Trade Agreement, provisions specifically related to medical devices Columbia and Panama Free Trade Agreements

LobbyistCovered position, as disclosed
STEVEN NEIL LAPIERRE —
MICHAEL MATTOON —

Contacted: SENATE; Pipeline & Hazardous Materials Safety Administration; Transportation, Dept of (DOT); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO)

Manufacturing MAN

Proposed rules regarding disclosure related to conflict minerals

LobbyistCovered position, as disclosed
JEAN CECIL FRICK —
MICHAEL MATTOON —

Contacted: Patent & Trademark Office (PTO); Transportation, Dept of (DOT); HOUSE OF REPRESENTATIVES; Pipeline & Hazardous Materials Safety Administration; Food & Drug Administration (FDA); SENATE

Taxation/Internal Revenue Code TAX

S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development Corporate tax reform- specifically the treatment of international earnings

LobbyistCovered position, as disclosed
BRENDA BECKER —
JEAN CECIL FRICK —
STEVEN NEIL LAPIERRE —
MICHAEL MATTOON —

Contacted: HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); SENATE; Food & Drug Administration (FDA); Transportation, Dept of (DOT); Pipeline & Hazardous Materials Safety Administration

Bills named: S. 17 (112th), S. 262 (112th), S. 239 (112th), H.R. 488 (112th), H.R. 436 (112th), H.R. 734 (112th), H.R. 942 (112th)

Health Issues HCR

Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research

LobbyistCovered position, as disclosed
JEAN CECIL FRICK —
STEVEN NEIL LAPIERRE —
MICHAEL MATTOON —

Contacted: Food & Drug Administration (FDA); Transportation, Dept of (DOT); SENATE; HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Pipeline & Hazardous Materials Safety Administration

Medicare/Medicaid MMM

S.454, Strengthening Program Integrity and Accountability in Health Care Act of 2011, a bill to prevent fraud, waste, and abuse under Medicare, Medicaid, and CHIP, and for other purposes H.R. 675, Strengthening Medicare Anti-Fraud Measures Act of 2011, to expand the permissive exclusion from participation in Federal health care programs to individuals and entities affiliated with sanctioned entities

LobbyistCovered position, as disclosed
STEVEN NEIL LAPIERRE —
MICHAEL MATTOON —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Pipeline & Hazardous Materials Safety Administration; Transportation, Dept of (DOT); Patent & Trademark Office (PTO)

Bills named: S. 454 (112th), H.R. 675 (112th)

Transportation TRA

H.R. 658, the FAA Reauthorization and Reform Act of 2011, provisions related to the transportation of lithium batteries S.223, the FAA Reauthorization and Reform Act of 2011, provisions related to the transportation of lithium batteries

LobbyistCovered position, as disclosed
BRENDA BECKER —
JEAN CECIL FRICK —
STEVEN NEIL LAPIERRE —
MICHAEL MATTOON —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Patent & Trademark Office (PTO); Transportation, Dept of (DOT); Pipeline & Hazardous Materials Safety Administration

Bills named: S. 223 (112th), H.R. 658 (112th)

Copyright/Patent/Trademark CPT

S.23, America Invents Act, provisions related specifically to patents and innovative technologies H.R. 1249, America Invents Act, provisions related specifically to patents and innovative technologies

LobbyistCovered position, as disclosed
BRENDA BECKER —
STEVEN NEIL LAPIERRE —
MICHAEL MATTOON —

Contacted: Pipeline & Hazardous Materials Safety Administration; Transportation, Dept of (DOT); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); SENATE; Food & Drug Administration (FDA)

Bills named: S. 23 (112th), H.R. 1249 (112th)

Budget/Appropriations BUD

Appropriations for the Food and Drug Administration Appropriations for pain management awareness programs

LobbyistCovered position, as disclosed
STEVEN NEIL LAPIERRE —
MICHAEL MATTOON —

Contacted: Patent & Trademark Office (PTO); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Pipeline & Hazardous Materials Safety Administration; Transportation, Dept of (DOT); SENATE

Education EDU

S.758, A bill to establish a Science, Technology, Engineering, and Math (STEM) Master Teacher Corps program S.716, Innovation Inspiration School Grant Program Act- to promote STEM education

LobbyistCovered position, as disclosed
JEAN CECIL FRICK —
MICHAEL MATTOON —

Contacted: Transportation, Dept of (DOT); SENATE; Food & Drug Administration (FDA); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Pipeline & Hazardous Materials Safety Administration

Bills named: S. 758 (112th), S. 716 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.